AUTL vs COP · rev $10.1M vs P/E 19, rev $58.94B
Autolus Therapeutics Ltd (AUTL) versus ConocoPhillips (COP) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Latest reported AUTL revenue for 2024-12-31 was $10.1M. Net income was -$220.7M. Revenue was up 496.0% from 2023-12-31 to 2024-12-31. AUTL currently screens at market cap $614.8M.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
AUTL currently screens at market cap $614.8M. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Not investment advice. Open the AUTL and COP stock pages for the full models.
Not investment advice.